Daniel M. Lewallen is a patent agent in the Intellectual Property Department in Barnes & Thornburg's Indianapolis office.
Prior to joining Barnes & Thornburg, Dr. Lewallen was a research associate with the Indiana University School of Medicine's Department of Biochemistry and Molecular Biology, where his efforts were focused on developing chemical probes for the Protein Tyrosine Phosphatases.
Dr. Lewallen was also a postdoctoral fellow with The Scripps Research Institute, where he established HTS campaigns for both the Protein Arginine Deiminases and the protein AMPylators. In addition to his screening efforts, Dr. Lewallen developed chemical probes to identify substrates of the Protein Arginine Deiminases both in cellulo and in human sera of diseased patients and also designed and synthesized inhibitors for the AMPylators.
Dr. Lewallen's doctorate thesis was focused on synthesizing complex carbohydrates for capturing and differentiating pathogens such as the influenza virus and pertussis toxin. In addition to synthesis, his research efforts focused on developing biophysical techniques to study the binding of carbohydrates and lectins. In total, Dr. Lewallen's research has been published in 10 different publications.